FDA & Prescription Drugs
One million packets of Pfizer birth control pills are now subject to a recall after a packaging error surfaced. The error could reduce the effectiveness of the birth control pills for those who…
FDA & Prescription Drugs
The FDA recently released an update on the surgical mesh implant devices based on an assessment of Medical Device Reports that were given to the FDA. The FDA is considering the recommendation…
FDA & Prescription Drugs
Millions of Americans turn to acne-fighting medications when it comes to clearing up their acne. And while many acne-treating medications are available to consumers, some acne-treating…
FDA & Prescription Drugs
Last week on October 27, 2011, federal health scientists reported that Yaz, the birth control drug manufactured by Bayer Healthcare as well as other newer birth control treatments increase the risk…
FDA & Prescription Drugs
As previously reported, Propecia must now warn its users that high-grade prostate cancer may result from the use of the hair loss prevention drug. The FDA has notified healthcare professionals…
FDA & Prescription Drugs
The FDA recently notified all healthcare professionals that the precautions section of labels for 5-aplha reductase inhibitor class of drugs should now include new safety information of the…
@large.jpg)
FDA & Prescription Drugs
An increased risk of developing bladder cancer has been linked to the diabetes drug Actos (generic: pioglitazone). The increased risk of developing bladder cancer is a staggering 40%. Actos was…
FDA & Prescription Drugs
Patients who have been taking ACTOS, a popular diabetes drug, have been warned by the FDA that there is an increase in the risk of bladder cancer when the drug is ingested for more than 12 months….
FDA & Prescription Drugs
The FDA recently issued a warning regarding ACTOS and the risk of developing bladder cancer. There have been recent studies suggesting that patients who take ACTOS longer than 12 months increase the…
FDA & Prescription Drugs
Actos (pioglitazaone) has recently been associated with the risk of bladder cancer, according to the FDA. On August 4, 2011, the FDA approved updated drug labels for the pioglitazone-containing…
FDA & Prescription Drugs
The epilepsy drug Topamax (topiramate) and its generic versions can increase the risk of oral birth defects (cleft lip and cleft palate), warns the Food and Drug Administration (FDA). Data…
FDA & Prescription Drugs
While many people have suffered some form of pain from Triad products, one group of people who are suffering not only painful outbreaks but potentially significant setbacks in their course of…